Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Santarus Inc. buy melinda

Santarus Inc.
Start price
€3.42
11.01.12 / 50%
Target price
€4.50
19.01.12
Performance (%)
-9.57%
End price
€3.09
19.01.12
Summary
This prediction ended on 19.01.12 with a price of €3.09. With a performance of -9.57%, the BUY prediction for Santarus Inc. by melinda closed slightly in the red. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Santarus Inc. - - - -
iShares Core DAX® -1,59 % 5,03 % 6,33 % 64,06 %
iShares Nasdaq 100 -4,15 % -0,13 % 25,73 % 86,92 %
iShares Nikkei 225® -6,30 % 0,53 % 41,38 % 77,87 %
iShares S&P 500 -3,23 % 0,47 % 20,45 % 68,19 %

Comments by melinda for this prediction

In the thread Santarus Inc. diskutieren
Prediction Buy
Perf. (%) -9.57%
Target price 4.500
Change
Ends at 19.01.12

Typ 2 Diabetes

Santarus Inc. ist ein biopharmazeutisches Unternehmen entwickelt und vermarktet Produkte für Miss Blutzuckerkontrolle bei Typ 2 Diabetikern

melinda 
0
Report Share
11.01.12
Prediction Buy
Perf. (%) -9.57%
Target price 4.500
Change
Ends at 19.01.12

(Vom Mitglied beendet)

melinda 
0
Report Share
19.01.12